Cargando…
IL-37 Was Involved in Progress of Acute Myeloid Leukemia Through Regulating IL-6 Expression
BACKGROUND: Interleukin-37, which was discovered in 2000, is a natural suppressor of immune and inflammatory responses. Recent studies reported that IL-37 was abnormally expressed in several tumor patients, including those with hepatocellular carcinoma, gastric cancer, lung cancer, colon cancer, epi...
Autores principales: | Wei, Xiaonan, Li, Yulan, Zhang, Guili, Wang, Na, Mi, Miaomiao, Xin, Yu, Jiang, Huihui, Sun, Chengming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064683/ https://www.ncbi.nlm.nih.gov/pubmed/33907463 http://dx.doi.org/10.2147/CMAR.S303017 |
Ejemplares similares
-
Circadian clock gene Period2 suppresses human chronic myeloid leukemia cell proliferation
por: Wang, Na, et al.
Publicado: (2020) -
Interleukin-37 is involved in the immunopathogenesis of infectious mononucleosis
por: Zhao, Mingsheng, et al.
Publicado: (2023) -
Role of IL-37- and IL-37-Treated Dendritic Cells in Acute Coronary Syndrome
por: Zhu, Ruirui, et al.
Publicado: (2021) -
The Role of IL-37 and IL-38 in Obstetrics Abnormalities
por: Wang, Mei
Publicado: (2021) -
The Role of IL-37 and IL-38 in Colorectal Cancer
por: Dang, Jie, et al.
Publicado: (2022)